Grasim
neutral mediumGrasim's Q2 FY24 consolidated revenue grew 10% YoY to INR 30,221 crore, with EBITDA up 14% to INR 4,509 crore, driven by cement and financial services.
Read Grasim analysis →Side-by-side earnings comparison across financial stats, AI summaries, management guidance, risks, quotes, and accountability signals.
Grasim's Q2 FY24 consolidated revenue grew 10% YoY to INR 30,221 crore, with EBITDA up 14% to INR 4,509 crore, driven by cement and financial services.
Read Grasim analysis →Bajaj Finserv delivered a strong Q2 FY24 with consolidated revenue up 25% YoY to INR 26,023 crore and PAT up 24% YoY to INR 1,929 crore.
Read Bajajfinsv analysis →Grasim's Q2 FY24 consolidated revenue grew 10% YoY to INR 30,221 crore, with EBITDA up 14% to INR 4,509 crore, driven by cement and financial services. Standalone revenue rose 4% to INR 6,442 crore, while EBITDA jumped 21% to INR 1,354 crore on higher VSF volumes (+24% YoY) and lower input costs. However, global price weakness in viscose and chloralkali persisted, and new businesses (paints, B2B e-commerce) incurred initial losses. Management guided for paints commercial launch in Q4 FY24 with three plants operational, and B2B platform Birla Pivot nearing INR 100 crore monthly run rate. Risks include sustained global demand softness in textiles and chemicals, and potential margin pressure from volatile input costs.
Bajaj Finserv delivered a strong Q2 FY24 with consolidated revenue up 25% YoY to INR 26,023 crore and PAT up 24% YoY to INR 1,929 crore. Growth was driven by robust performance across subsidiaries: BAGIC reported a 95.3% combined ratio (lowest in 14 quarters) and 39% PAT growth, while BALIC saw NBV growth of 25% to INR 237 crore. BFL continued its momentum with 33% AUM growth and asset quality improvement. The AMC business launched with INR 5,235 crore AUM. Management guided for continued balanced growth, with BAGIC targeting sub-100% combined ratio despite near-term investment costs. Key risk: elevated claims volatility in government health and crop insurance segments could pressure underwriting profitability.
Viscose staple fiber sales volume grew 24% year-over-year in Q2 FY24.
Caustic soda sales volume increased 3% year-over-year in Q2 FY24.
Epoxy business recorded 25% volume growth year-over-year in Q2 FY24.
B2B e-commerce platform Birla Pivot crossed INR 100 crore revenue in Q2 FY24.
Lowest combined ratio in 14 quarters, driven by better expense ratios and reinsurance terms.
New business value growth supported by improved product mix and interest rate movement.
Strong AUM growth driven by diversified business model and customer acquisition.
Market share doubled from ~4% two years ago, driven by OEM tie-ups and long-term policies.
Three plants (Panipat, Ludhiana, Cheyyar) have received consent to operate and will be operational in Q4 FY24, with product launch in the same quarter.
Management guidance expansionThe expanded epoxy capacity is under commissioning and expected to be operational in Q3 FY24.
Management guidance expansionProjects under implementation of about 1 GW are expected to be commissioned by next year's first quarter.
Management guidance expansionEven with full paints CapEx next fiscal, debt-to-EBITDA is not expected to cross about 3.5x.
Management guidance otherDue to investments in manpower and rural expansion, combined ratio may temporarily exceed 100% before normalizing.
Management guidance marginsManagement expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.
Management guidance growthBFL continues to deliver on AUM growth, profitability, and asset quality targets as per its stated guidance.
Management guidance growthInternational brands continue to hold elevated inventories, suppressing demand for VSF and VFY; recovery timeline remains uncertain.
high · management_commentaryCaustic soda, sulfur, coal, and oil prices are volatile; recent stabilization and upticks could pressure margins.
medium · management_commentaryInitial costs from paints business are being charged to P&L, with losses expected to persist until commercial launch and scale-up.
medium · analyst_questionAnti-dumping duty on VFY is only at DGTR recommendation stage; Chinese imports continue to pressure domestic prices due to low domestic consumption in China.
medium · analyst_questionThe Gujarat government health scheme may have higher loss ratios due to backlog claims, though 80% is reinsured.
medium · management_commentaryBAGIC's expense ratio may rise as investments in manpower and rural branches continue, impacting near-term profitability.
medium · management_commentaryAnalyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.
medium · analyst_questionHigher share of lower-margin products (ULIP, non-par) and investments in new channels may keep VNB margins below prior year levels.
medium · analyst_questionThe international demand for textiles, in general, has been subdued for last 4 or 6 quarters. And the international brands have been saddled with huge inventory for multiple reasons, and they have been trying to correct their inventories by purchasing less.
We will be launching our paints in Q4, so which is in the period January, February, March. And also the three of our plants, which we have disclosed, also in the report that you have in Ludhiana, Panipat, and Cheyyar, they have got their CTO, so they are expected to become operational in Q4.
We have never done business in a desperate manner. We have always done business the way business should be done.
Our purpose is to create platform to carry out health transactions for customers. It's not about acquiring customers, it's all about enabling transactions digitally.